Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls

American Journal of Pathology

Volumn 167, Issue 2, 2005, Pages 527-543

  Kumar Singh, Samir ^a,f   Pirici, Daniel ^a   McGowan, Eileen ^c   Serneels, Sally ^a   Ceuterick, Chantal ^b   Hardy, John ^d   Duff, Karen ^e   Dickson, Dennis ^c   Van Broeckhoven, Christine ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c MAYO GRADUATE SCHOOL   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^f UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; IMMUNOGLOBULIN; PLASMA PROTEIN; PRESENILIN 1; PRESENILIN 2; MEMBRANE PROTEIN; SERUM ALBUMIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL WALL; BRAIN HEMORRHAGE; COMPUTER SIMULATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; IMMUNOGOLD LABELING; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; QUANTITATIVE ANALYSIS; SENILE PLAQUE; STEREOLOGY; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; ANIMAL; BLOOD; BRAIN; BRAIN CIRCULATION; C57BL MOUSE; DISEASE MODEL; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULINS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRESENILIN-1; SENILE PLAQUES; SERUM ALBUMIN;

EID: 25144503548     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62995-1     Document Type: Article

References (62)

1. Hardy JA, Higgins GA: Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256:184-185
2. Van Broeckhoven C: Molecular genetics of Alzheimer disease: identification of genes and gene mutations. Eur Neurol 1995, 35:8-19
3. Selkoe DJ: The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 1998, 8:447-453
4. Dickson DW: The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997, 56:321-339
5. Yankner BA, Duffy LK, Kirschner DA: Neurotrophic and neurotoxic effects of amyloid beta-protein-reversal by tachykinin neuropeptides. Science 1990, 250:279-282
6. Joachim CL, Morris JH, Selkoe DJ: Clinically diagnosed Alzheimers-disease-autopsy results in 150 cases. Ann Neurol 1988, 24:50-56
7. Scholtz W: Studien zur Pathologie der Hirngefässe. II. Die drüsige Entartung der Hirnarterien und-capillären. Z Gesamte Neurol Psychiat 1938, 162:694-715
8. Ishii T: Enzyme histochemical studies of senile plaques and the plaque-like degeneration of arteries and capillaries (Scholz). Acta Neuropathol (Berl) 1969, 14:250-260
9. Mandybur TI: The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology 1975, 25:120-126
10. Glenner GG: Amyloid deposits and amyloidosis. N Engl J Med 1980, 302:1283-1292
11. Miyakawa T, Shimoji A, Kuramoto R, Higuchi Y: The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Morphological mechanism of senile plaque production. Virchows Arch B Cell Pathol Incl Mol Pathol 1982, 40:121-129
12. Arai H, Sagi N, Noguchi I, Haga S, Ishii T, Makino Y, Kosaka K: An immunohistochemical study of beta-protein in Alzheimer-type dementia brains. J Neurol 1989, 236:214-217
13. Kawai M, Kalaria RN, Harik Si, Perry G: The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am J Pathol 1990, 137:1435-1446
14. Iwamoto N, Nishiyama E, Ohwada J, Arai H: Distribution of amyloid deposits in the cerebral white matter of the Alzheimer's disease brain: relationship to blood vessels. Acta Neuropathol (Berl) 1997, 93:334-340
15. Kumar-Singh S, Cras P, Wang R, Kros JM, van Swieten J, Lubke U, Ceuterick C, Serneels S, Vennekens K, Timmermans J-P, Van Marck E, Martin J-J, van Duijn C, Van Broeckhoven C: Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric. Am J Pathol 2002, 161:507-520
16. Vinters HV, Wang ZZ, Secor DL: Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol 1996, 6:179-195
17. Morel F, Wildi E: General and cellular pathochemistry of senile and presenile alterations of the brain. Proc 1st Int Cong Neuropathol Rome 1952, 347-374
18. Peers MC, Lenders MB, Defossez A, Delacourte A, Mazzuca M: Cortical angiopathy in Alzheimers-disease-the formation of dystrophic perivascular neurites is related to the exudation of amyloid fibrils from the pathological vessels. Virchows Arch A Pathol Anat Histopathol 1988, 414:15-20
19. Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, Warren A, McInnis MG, Antonarakis SE, Martin J-J, Hofman A, Van Broeckhoven C: Presenile dementia and cerebral haemorrhage linked to a mutation at condon 692 of the β-amyloid precursor protein gene. Nat Genet 1992, 1:218-221
20. Dermaut B, Kumar-Singh S, De Jonghe C, Cruts M, Lofgren A, Lubke U, Cras P, Dom R, De Deyn PP, Martin JJ, Van Broeckhoven C: Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation. Brain 2001, 124:2383-2392
21. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnsonwood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoyazavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J: Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 1995, 373:523-527
22. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G: Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996, 274:99-102
23. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K: Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 1998, 4:97-100
24. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B: Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 1997, 94:13287-13292
25. Urbane B, Cruz L, Le R, Sanders J, Ashe KH, Duff K, Stanley HE, Irizarry MC, Hyman BT: Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc Natl Acad Sci USA 2002, 99:13990-13995
26. Farkas E, Luiten PGM: Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 2001, 64:575-611
27. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S: Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 1996, 383:710-713
28. Kumar-Singh S, De Jonghe C, Cruts M, Kleinert R, Wang R, Mercken M, De Strooper B, Vanderstichele H, Lofgren A, Vanderhoeven I, Backhovens H, Vanmechelen E, Kroisel PM, Van Broeckhoven C: Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated abeta(42) in Alzheimer's disease. Hum Mol Genet 2000, 9:2589-2598
29. Kumar-Singh S, Vermeulen PB, Weyler J, Segers K, Weyn B, Van Daele A, Van Oosterom AT, Dirix LY, Van Marck E: Evaluation of tumour angiogenesis as a prognostic marker in malignant mesothelioma. J Pathol 1997, 182:211-216
30. Maxwell MH: Two rapid and simple methods for the removal of resins from 1.0 micrometer thick epoxy sections. J Microsc 1977, 112:253-255
31. McGowan E, Sanders S, Iwatsubo T, Takeuchi A, Saido T, Zehr C, Yu X, Uljon S, Wang R, Mann D, Dickson D, Duff K: Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol Dis 1999, 6:231-244
32. Matsuoka Y, Picciano M, Malester B, LaFrancois J, Zehr C, Daeschner JM, Olschowka JA, Fonseca MI, O'Banion MK, Tenner AJ, Lemere CA, Duff K: Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am J Pathol 2001, 158:1345-1354
33. Callahan MJ, Lipinski WJ, Bian F, Durham RA, Pack A, Walker LC: Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am J Pathol 2001, 158:1173-1177
34. Wang J, Tanila H, Puolivali J, Kadish I, van Groen T: Gender differences in the amount and deposition of amyloid beta in APPswe and PS1 double transgenic mice. Neurobiol Disease 2003, 14:318-327
35. Yamaguchi H, Yamazaki T, Lemere CA, Frosch MP, Selkoe DJ: Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study. Am J Pathol 1992, 141:249-259
36. Winkler DT, Bondolfi L, Herzig MC, Jann L, Calhoun ME, Wiederhold KH, Tolnay M, Staufenbiel M, Jucker M: Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci 2001, 21:1619-1627
37. de la Torre JC: Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004, 3:184-190
38. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M: Beta-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 1996, 380:168-171
39. Kalaria RN, Hedera P: Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuroreport 1995, 6:477-480
40. Perlmutter LS, Chui HC: Microangiopathy, the vascular basement-membrane and Alzheimers-disease-a review. Brain Res Bull 1990, 24:677-686
41. Mooradian AD: Effect of aging on the blood-brain-barrier. Neurobiol Aging 1988, 9:31-39
42. Poduslo JF, Curran GL, Wengenack TM, Malester B, Duff K: Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease. Neurobiol Disease 2001, 8:555-567
43. Cras P, van Harskamp F, Hendriks L, Ceuterick C, van Duijn CM, Stefanko SZ, Hofman A, Kros JM, Van Broeckhoven C, Martin JJ: Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala->Gly mutation. Acta Neuropathol 1998, 96:253-260
44. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K: Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 1998, 4:97-100
45. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ: Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 1996, 3:16-32
46. Hayashi H, Kimura N, Yamaguchi H, Hasegawa K, Yokoseki T, Shibata M, Yamamoto N, Michikawa M, Yoshikawa Y, Terao K, Matsuzaki K, Lemere CA, Selkoe DJ, Naiki H, Yanagisawa K: A seed for Alzheimer amyloid in the brain. J Neurosci 2004, 24:4894-4902
47. Savage MJ, Trusko SP, Howland DS, Pinsker LR, Mistretta S, Reaume AG, Greenberg BD, Siman R, Scott RW: Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester. J Neurosci 1998, 18:1743-1752
48. Selkoe DJ: Clearing the brain's amyloid cobwebs. Neuron 2001, 32:177-180
49. Tucker HM, Kihiko M, Caldwell JN, Wright S, Kawarabayashi T, Price D, Walker D, Scheff S, McGillis JP, Rydel RE, Estus S: The plasmin system is induced by and degrades amyloid-beta aggregates. J Neurosci 2000, 20:3937-3946
50. Meyer-Luehmann M, Stalder M, Herzig MC, Kaeser SA, Kohler E, Pfeifer M, Boncristiano S, Mathews PM, Mercken M, Abramowski D, Staufenbiel M, Jucker M: Extracellular amyloid formation and associated pathology in neural grafts. Nat Neurosci 2003, 6:370-377
51. Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, Abramowski D, Sturchler-Pierrat C, Sommer B, Staufenbiel M, Jucker M: Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 1999, 96:14088-14093
52. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV: Clearance of Alzheimer's amyloid-ss(1-40) peptide irom brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 2000, 106:1489-1499
53. Zlokovic BV: Clearing amyloid through the blood-brain barrier. J Neurochem 2004, 89:807-811
54. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE: Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998, 153:725-733
55. Deane R, Du YS, Submamaryan RK, Larue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B: RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 2003, 9:907-913
56. Van Dorpe J, Smeijers L, Dewachter I, Nuyens D, Spittaels K, Van Den HC, Mercken M, Moechars D, Laenen I, Kuiperi C, Bruynseels K, Tesseur I, Loos R, Vanderstichele H, Checler F, Sciot R, Van Leuven F: Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am J Pathol 2000, 157:1283-1298
57. Frackowiak J, Miller DL, Potempska A, Sukontasup T, Mazur-Kolecka B: Secretion and accumulation of A beta by brain vascular smooth muscle cells from A beta PP-Swedish transgenic mice. J Neuropathol Exp Neurol 2003, 62:685-696
58. Deane R, Wu ZH, Sagare A, Davis J, Yan SD, Hamm K, Xu F, Parisi M, Larue B, Hu HW, Spijkers P, Quo H, Song XM, Lenting PJ, Van Nostrand WE, Zlokovic BV: LRP/amyloid beta-peptide interaction mediates differential brain efflux of A beta isoforms. Neuron 2004, 43:333-344
59. Collins SR, Douglass A, Vale RD, Weissman JS: Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLOS Biol 2004, 2:E321
60. Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E, Sekine-Aizawa Y, Saido TC: Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 2000, 6:143-150
61. DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM: Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 2002, 295:2264-2267
62. Matsuoka Y, Saito M, LaFrancois J, Saito M, Gaynor K, Olm V, Wang LL, Casey E, Lu YF, Shiratori C, Lemere C, Duff K: Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid. J Neurosci 2003, 23:29-33